Promoting Overall Care and Management Related to Tuberculosis Infection Through Pharmaceutical Care and Text Messaging
NCT04264221 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 600
Last updated 2020-12-02
Summary
This project aims to standardize the management of "Pharmaceutical care with the two-way text messages and incentive for mobile usage during the treatment for tuberculosis patients, to improve the outcomes and compliance, reduce the risk of transmission and to evaluate the patient perspective in terms of their quality of life, shared decision making and satisfaction with services provided.
Conditions
- Pulmonary TB
Interventions
- BEHAVIORAL
-
New management mode
* New management mode intervention: Pharmaceutical care * SMS text messages and Phone Calls * Behavioural Educational leaflet * Self-Administered Therapy A financial incentive for mobile use
Sponsors & Collaborators
-
Shaheed Zulfiqar Ali Bhutto Medical University Islamabad Pakistan
collaborator UNKNOWN -
Pakistan Institute of Medical Sciences
collaborator OTHER_GOV -
Quaid i Azam University Islamabad Pakistan
collaborator UNKNOWN -
Farman Ullah Khan
lead OTHER
Principal Investigators
-
Yu Fang, Phd · Xian Jiaotong University China
-
Asim ur Re, Phd · Quaid i Azam University Islamabad Pakistan
-
Farman Ull ah Khan, Phd · Jiaotong University Islamabad Pakistan
Study Design
- Allocation
- RANDOMIZED
- Purpose
- HEALTH_SERVICES_RESEARCH
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 78 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2020-02-01
- Primary Completion
- 2020-12-01
- Completion
- 2020-12-01
Countries
- Pakistan
Study Locations
More Related Trials
-
A Controlled Smoking Cessation Trial and Prospective Cohort Study of Tuberculosis (TB) Treatment Outcomes
NCT02238405 ·Status: COMPLETED ·Phase: NA
-
A Study of the Safety, Tolerability, and Absorption, Metabolism, and Excretion of PA-824 in Healthy Adult Male Subjects.
NCT03202693 ·Status: COMPLETED ·Phase: PHASE1
-
Reactogenicity, Safety and Immunogenicity of a TB/FLU-04L Tuberculosis Vaccine
NCT02501421 ·Status: COMPLETED ·Phase: PHASE1
-
Treatment Adherence of Tuberculosis Medicines
NCT01471977 ·Status: COMPLETED ·Phase: NA
-
SMS-based Mobile Health Intervention for Nutritional Status and Treatment Outcome Among TB Patients
NCT04242472 ·Status: UNKNOWN ·Phase: NA
-
Innovative Approach in Tuberculosis Care in Armenia
NCT02082340 ·Status: COMPLETED ·Phase: NA
-
Steroids vs Placebo in Treatment of Tuberculous Lymphadenitis
NCT06236152 ·Status: COMPLETED ·Phase: NA
-
Short Course Regimen in Low Risk Active Tuberculosis- a Multicenter, Randomized, Active-controlled, Trial
NCT06727864 ·Status: RECRUITING ·Phase: PHASE3
-
Pharmacist-Led Intervention to Improve TB Treatment Adherence
NCT06608069 ·Status: COMPLETED ·Phase: NA
-
Promoting Adherence to Treatment for Latent TB Infection Through Text Messaging
NCT02690818 ·Status: COMPLETED ·Phase: NA
-
Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Ex-vivo Antitubercular Activity of PBTZ169 Formulation
NCT03423030 ·Status: COMPLETED ·Phase: PHASE1
-
Optimal Treatment Duration for Radiographically Apparent, Bacteriologically Unconfirmed TB, Identified Through Active Case Finding (RADIO-TB Trial)
NCT07163143 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
Evaluation of Early Bactericidal Activity in Pulmonary Tuberculosis (CL-010)
NCT00944021 ·Status: COMPLETED ·Phase: PHASE2
-
TB YOUTH - TB sYstemic Management Using One-month, Ultra-short TPT Regimen for scHool Contacts
NCT06022146 ·Status: RECRUITING ·Phase: PHASE3
-
Ultra-Short Regimen for Elderly DS-TB
NCT07076225 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
Azacytidine During Anti-tuberculosis Therapy
NCT03941496 ·Status: WITHDRAWN ·Phase: PHASE1/PHASE2
-
Safety and Effectiveness of Delamanid-containing Regimen for MDR-TB Patients in China
NCT04421495 ·Status: UNKNOWN ·Phase: PHASE4
-
Acute Presentation and Management of Abdominal Tuberculosis: A Ten-year Experience at a Tertiary Care Center in Pakistan
NCT03918226 ·Status: COMPLETED ·Phase: NA
-
Efficacy and Safety of Modified Anti-tubercular Regimens in Treatment of Tuberculosis in Patients With Underlying Compensated and Decompensated Chronic Liver Disease
NCT01677871 ·Status: UNKNOWN ·Phase: NA
-
A Multiple Ascending Dose Study With a Dose Formulation Comparison Cohort to Evaluate the Safety, Tolerability, and Pharmacokinetics of TBA-354 in Healthy Adult Subjects
NCT02606214 ·Status: TERMINATED ·Phase: PHASE1
-
Expand New Drugs for TB [endTB]
NCT03259269 ·Status: COMPLETED
-
The Effect of Telephone Follow-up and Training on Treatment Adherence in Tuberculosis Patients and Contacts
NCT05202431 ·Status: COMPLETED ·Phase: NA
-
Efficacy and Safety of Immunomodulator as an Adjunct Therapy in New Pulmonary Tuberculosis(Category I) Patients.
NCT00341328 ·Status: COMPLETED ·Phase: PHASE3
-
Pharmacist-led Digital Interventions to Improve Tuberculosis Treatment Adherence
NCT07069387 ·Status: RECRUITING ·Phase: NA
-
Real-time Tuberculosis Medication Adherence Intervention in Rural Southwestern Uganda
NCT03800888 ·Status: UNKNOWN ·Phase: NA